Table 1.
Demographics of the TPCH-KCO set (n = 29 patients) used in microRNA microarrays
|
TPCH-KCO set |
||
|---|---|---|
| Mild emphysema | Moderate emphysema | |
| n |
9 |
20 |
| Age (Mean ± SD yrs) |
70 ± 4 |
67 ± 7 |
| Range |
63-74 |
53-78 |
| Male/Female |
7/2 |
14/6 |
| FEV1 % predicted (Mean ± SD) |
80 ± 17 |
68 ± 15 |
| Range |
52-107 |
50-97 |
| FEV1/VC (Mean ± SD) % |
59 ± 5 |
54 ± 14 |
| Range |
50-70 |
40-70 |
| KCO % predicted (Mean ± SD) |
79 ± 3 |
66 ± 9 |
| Range |
75-85 |
38-74 |
| Pack years (Mean ± SD) |
62 ± 34 |
75 ± 49 |
| Range |
28-135 |
24-240 |
| Site of tissue collection |
1-LLL |
1-LL |
| 1-RLL |
5-LUL |
|
| 1-LL |
7-RLL |
|
| 1-RL |
5-RUL |
|
| 5-RUL |
2-RML |
|
| GOLD Stage I Mild (FEV1 ≥80% predicted) |
4 |
3 |
| GOLD Stage II Moderate (50 < FEV1 < 80% predicted) | 5 | 17 |
List of abbreviations, FEV1 forced expired volume in one second, VC vital capacity, KCO transfer coefficient of carbon monoxide, SD standard deviation, LLL left lower lobe, RLL right lower lobe, LUL left upper lobe, RUL right upper lobe, RML right middle lobe, LL left lung, RL right lung.